SNNAQ (Sienna Biopharmaceuticals) Total Equity: $23.10 Mil (As of Sep. 2019)


What is Sienna Biopharmaceuticals Total Equity?

Sienna Biopharmaceuticals SNNAQ -99.00% Total Equity is $23.10 Mil as of Sep. 2019.

Sienna Biopharmaceuticals's total equity for the quarter that ended in Sep. 2019 was $23.10 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Sienna Biopharmaceuticals Total Equity Historical Data

* Premium members only.

The historical data trend for Sienna Biopharmaceuticals's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sienna Biopharmaceuticals Total Equity Chart

Sienna Biopharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18
Total Equity
4.05 22.12 91.20 26.58

Sienna Biopharmaceuticals Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.93 26.58 33.29 26.98 23.10

Sienna Biopharmaceuticals Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Sienna Biopharmaceuticals's Total Equity for the fiscal year that ended in Dec. 2018 is calculated as

Total Equity=Total Assets(Q: Dec. 2018 )-Total Liabilities(Q: Dec. 2018 )
=107.306-80.725
=26.58

Sienna Biopharmaceuticals's Total Equity for the quarter that ended in Sep. 2019 is calculated as

Total Equity=Total Assets(Q: Sep. 2019 )-Total Liabilities(Q: Sep. 2019 )
=43.492-20.391
=23.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $23.10 Mil mean?
Sienna Biopharmaceuticals (SNNAQ) has a Total Equity of $23.10 Mil as of Sep. 2019. The total amount of equity as record on a company's balance sheet. View historical data for Sienna Biopharmaceuticals and its competitors.
Is Sienna Biopharmaceuticals' Total Equity too high?
Sienna Biopharmaceuticals' current Total Equity is $23.10 Mil.
How does Sienna Biopharmaceuticals' Total Equity compare to GTHR and PPCB?
Sienna Biopharmaceuticals' Total Equity of $23.10 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Sienna Biopharmaceuticals and its competitors. Sienna Biopharmaceuticals's current Total Equity is $23.10 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sienna Biopharmaceuticals stock overvalued right now?
Sienna Biopharmaceuticals (SNNAQ) has a current Total Equity of $23.10 Mil. The current Total Equity is $23.10 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Sienna Biopharmaceuticals (SNNAQ), the current Total Equity is $23.10 Mil as of Sep. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sienna Biopharmaceuticals Business Description

Address 30699 Russell Ranch Road, Suite 140, Westlake Village, CA, USA, 91362
Sienna Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on bringing innovations in biotechnology to the discovery, development, and commercialization of first-in-class, targeted, topical products in medical dermatology and aesthetics. The objective is to develop multi-asset pipeline of topical therapies that enhance the health, appearance, and quality of life of dermatology patients. The product portfolio includes SNA-120, SNA-125, and SNA-001.